RWA Wealth Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.3M | Buy |
110,763
+7,901
| +8% | +$912K | 0.15% | 90 |
|
|
2025
Q4 | $10.8M | Sell |
102,862
-8,889
| -8% | -$834K | 0.12% | 104 |
|
|
2025
Q3 | $9.38M | Sell |
111,751
-44,217
| -28% | -$3.64M | 0.11% | 118 |
|
|
2025
Q2 | $12.3M | Sell |
155,968
-392,016
| -72% | -$31.2M | 0.15% | 89 |
|
|
2025
Q1 | $49.2M | Buy |
547,984
+1,394
| +0.3% | +$130K | 0.62% | 25 |
|
|
2024
Q4 | $54.4M | Buy |
546,590
+207,497
| +61% | +$21.4M | 0.67% | 23 |
|
|
2024
Q3 | $38.5M | Buy |
339,093
+54,683
| +19% | +$6.5M | 0.48% | 32 |
|
|
2024
Q2 | $35.2M | Buy |
284,410
+191
| +0.1% | +$24.6K | 0.46% | 34 |
|
|
2024
Q1 | $37.5M | Sell |
284,219
-9,463
| -3% | -$1.17M | 0.5% | 31 |
|
|
2023
Q4 | $32M | Buy |
293,682
+159,612
| +119% | +$16.6M | 0.46% | 33 |
|
|
2023
Q3 | $13.8M | Buy |
134,070
+6,787
| +5% | +$732K | 0.3% | 32 |
|
|
2023
Q2 | $14.7M | Buy |
127,283
+27,396
| +27% | +$3.11M | 0.32% | 30 |
|
|
2023
Q1 | $10.6M | Buy |
99,887
+1,873
| +2% | +$202K | 0.26% | 36 |
|
|
2022
Q4 | $10.9M | Buy |
98,014
+3,833
| +4% | +$392K | 0.27% | 35 |
|
|
2022
Q3 | $8.11M | Buy |
94,181
+1,410
| +2% | +$126K | 0.57% | 37 |
|
|
2022
Q2 | $8.46M | Buy |
92,771
+3,033
| +3% | +$269K | 0.57% | 38 |
|
|
2022
Q1 | $7.36M | Buy |
89,738
+6,867
| +8% | +$541K | 0.48% | 57 |
|
|
2021
Q4 | $6.35M | Sell |
82,871
-18,120
| -18% | -$1.44M | 0.43% | 69 |
|
|
2021
Q3 | $7.58M | Buy |
100,991
+534
| +0.5% | +$40.6K | 0.57% | 52 |
|
|
2021
Q2 | $7.81M | Sell |
100,457
-1,044
| -1% | -$77.7K | 0.58% | 48 |
|
|
2021
Q1 | $7.47M | Buy |
101,501
+17,114
| +20% | +$1.26M | 0.6% | 48 |
|
|
2020
Q4 | $6.59M | Buy |
84,387
+27,393
| +48% | +$2.1M | 0.58% | 42 |
|
|
2020
Q3 | $4.51M | Sell |
56,994
-9
| -0% | -$705 | 0.47% | 53 |
|
|
2020
Q2 | $4.21M | Buy |
57,003
+41,703
| +273% | +$3.14M | 0.51% | 51 |
|
|
2020
Q1 | $1.12M | Buy |
15,300
+3,752
| +32% | +$295K | 0.16% | 90 |
|
|
2019
Q4 | $1M | Buy |
11,548
+71
| +0.6% | +$5.83K | 0.1% | 119 |
|
|
2019
Q3 | $922K | Buy |
11,477
+481
| +4% | +$38.5K | 0.1% | 127 |
|
|
2019
Q2 | $880K | Sell |
10,996
-1,039
| -9% | -$79.6K | 0.09% | 131 |
|
|
2019
Q1 | $955K | Hold |
12,035
| – | – | 0.11% | 120 |
|
|
2018
Q4 | $878K | Buy |
12,035
+1,843
| +18% | +$130K | 0.12% | 115 |
|
|
2018
Q3 | $690K | Sell |
10,192
-349
| -3% | -$22.2K | 0.08% | 128 |
|
|
2018
Q2 | $611K | Buy |
10,541
+7,203
| +216% | +$406K | 0.07% | 143 |
|
|
2018
Q1 | $173K | Sell |
3,338
-9,346
| -74% | -$505K | 0.02% | 206 |
|
|
2017
Q4 | $681K | Sell |
12,684
-912
| -7% | -$50.6K | 0.08% | 143 |
|
|
2017
Q3 | $831K | Buy |
13,596
+829
| +6% | +$50.3K | 0.09% | 124 |
|
|
2017
Q2 | $781K | Buy |
12,767
+227
| +2% | +$13.8K | 0.1% | 112 |
|
|
2017
Q1 | $760K | Buy |
+12,540
| New | +$761K | 0.1% | 106 |
|
Other funds holding MRK
VCM
VPM
RWA Wealth Partners's MRK Position: Q1 2026 in Review
RWA Wealth Partners increased its Merck (MRK) stake by 7.7% in Q1 2026, buying an estimated $912K and bringing the position to 110,763 shares worth $13.3M. The position accounts for 0.15% of the portfolio, ranked #90.
RWA Wealth Partners first reported a position in MRK in Q1 2017 and has held it in 37 quarters since. The position peaked at $54.4M in Q4 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- RWA Wealth Partners held 110,763 shares of Merck worth $13.3M as of Q1 2026.
- RWA Wealth Partners bought 7,901 Merck shares in Q1 2026, an estimated $912K.
- Merck made up 0.15% of RWA Wealth Partners's portfolio in Q1 2026, its #90 holding.
- RWA Wealth Partners first reported a position in Merck in Q1 2017 and has held it in 37 quarters since.
- RWA Wealth Partners's Merck position peaked at $54.4M in Q4 2024.
- 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on RWA Wealth Partners's 13F filing for Q1 2026, filed 13 May 2026.